c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Viridian Therapeutics (VRDN) Reports Promising Phase 1 Data for VRDN-008 FcRn Inhibitor
GuruFocus | Nov 9, 2026 7:28 AM EST
Related Stocks: VRDN ,
Read original article